Nom du produit:tetrasodium;5-[[[(1S)-1-(4-bromophenyl)ethyl]amino]-phosphonatomethyl]quinoxaline-2,3-diolate
IUPAC Name:tetrasodium 5-({[(1S)-1-(4-bromophenyl)ethyl]amino}(phosphonato)methyl)quinoxaline-2,3-bis(olate)
- CAS:2102348-87-6
- Formule moléculaire:C17H13BrN3Na4O5P
- Pureté:95%+
- Numéro de catalogue:CM674053
- Poids moléculaire:542.14
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2102348-87-6
- Formule moléculaire:C17H13BrN3Na4O5P
- Point de fusion:-
- Code SMILES:[Na+].[Na+].[Na+].[Na+].C[C@H](NC(C1=CC=CC2=NC([O-])=C([O-])N=C12)P([O-])([O-])=O)C1=CC=C(Br)C=C1
- Densité:
- Numéro de catalogue:CM674053
- Poids moléculaire:542.14
- Point d'ébullition:
- N° Mdl:MFCD08705420
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.